Recursion reported two confirmed responses in endometrial cancer and a 91.7% disease-control rate at doses of 45 mg or higher; Sanofi optioned a candidate.

At the dawn of the era where AI improves AI, I will write about what I, as someone in the field, have been thinking.ELYZA ...

Recursion Pharmaceuticals Inc. stocks have been trading down by -10.42 percent after bearish sentiment over slowing pipeline progress. Key Takeaways RXRX is pulling back after a failed push above $5, ...

Recursion Pharmaceuticals Inc. stocks have been trading down by -4.43 percent after AI drug-discovery partnership concerns ...

MIT’s Alex Zhang reveals why OpenAI and Anthropic coding agents are basically the same, sparking debate in AI development ...

Right now, leading artificial intelligence models need human supervision to improve—but a popular theory known as "recursive ...

"AI will start creating smarter AI on its own."Hearing that might sound a bit like science fiction.But right now, the concept ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.70, marking a -1.2% move from the previous day. The stock's performance was behind the S&P 500's daily loss of 0.77%. On ...

Recursive self-improvement in AI is the idea that an AI system improves not only its task performance, but also the process it uses to improve itself. That second part matters. A chatbot that rewrites ...

The last few weeks have seen a deluge of news about AI – from models going rogue to doom predictions about how AI could cause the end of humanity. People in the AI industry often use terms like “AGI,” ...

SMELT 让 Transformer 的中间层执行第二次前向计算，并在严格匹配每个 token 的 FLOPs、非嵌入参数量和 KV Cache 的条件下进行对比。 这期视频讲解中间层循环、残差缩放、注意力沉降、长上下文表现 ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...